Best Caddo Parish Grants for Nonprofits in Louisiana

Whitley County Builders’ Association Scholarship

This scholarship is available to a graduating senior who attends Columbia City High School, Churubusco High School, or Whitko High School and is planning to pursue a technical, associate or baccalaureate degree in the building trades field (such as Construction Engineer, Architecture, Building trades, etc.)

Philip & Leta Shriver Scholarship

Philip Shriver grew up in rural South Whitley and graduated from South Whitley High School. Leta Bernice Keel graduated from South Whitley High School in 1940. The two married on April 4, 1943. They made their home on a farm in rural South Whitley.

Leta was employed by Virgil Heinselman’s Locker and G & G Grocery. She was a member of the South Whitley United Methodist Church until she died on June 26, 2005.

A career-long farmer, Phil had a large chicken and egg operation for years, maintaining over 5000 chickens. An advocate for the industry, he was instrumental in stopping an egg carton tax proposed by the State of Ohio. He also worked construction for Morris Darley of South Whitley for many years. Phil was an accomplished welder and metal fabricator, making several crosses that adorn the steeples of area churches.

This scholarship was created as a gift from the estate of Philip Shriver after his death in 2021. It is open to any Whitley County graduating senior who plans to further their education in the field of agriculture or church-related work.

Whitley County 4-H Helping Hands Scholarship

This scholarship will go to a Whitley County senior involved with 4-H. Please contact the 4-H Extension Office for more information. The recipient will be selected during the Whitley County 4-H fair.

The Melanoma Career Development Award (CDA) is offered by the Melanoma Research Foundation to support researchers dedicated to melanoma and its prevention. This award is designed for postdoctoral fellows with under five years of experience, research associates, scientists, staff scientists, assistant professors, and those focusing on melanoma prevention. The initiative promotes innovative research to advance understanding and treatment of melanoma, ultimately aiming to reduce its impact.

The Cooperative Education Fund, managed by the Cooperative Development Foundation, offers grants, scholarships, and sponsorships to support cooperative education initiatives. Annually, it allocates between $100,000 and $140,000, providing 10-15 grants ranging from $1,000 to $10,000. Eligible applicants include cooperatives and related organizations within the U.S. The Fund prioritizes research, educational material development, and sponsorship for educational events, ensuring resources remain accessible and non-proprietary.

The Cooperative Development Fund Grant supports cooperative development, research, and technical assistance for cooperatives focused on seniors, international development, and affordable housing. Grants, typically ranging from $20,000 to $30,000, are awarded once a year, with a two-stage application process: a concept paper followed by a full proposal for selected applicants. Up to two grants are awarded annually, with decisions announced shortly after the Advisory Board meeting in January.

The Spark Good: Strengthening Community Local Grants program by the Wal-Mart Foundation empowers local organizations through grants ranging from $250 to $5000. This initiative aims to enhance community welfare by supporting diverse projects, including animal shelters and educational programs. Eligible organizations must have a verified Spark Good account, ensuring funds are allocated effectively to meet local needs and foster community development. Together, we can create lasting impacts through small yet significant actions.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on supporting nonprofit organizations that enhance patient access to treatment in cardiovascular and metabolic health. Applications are encouraged for initiatives that promote education, empower patients, and address healthcare disparities. Eligible organizations must be IRS 501(c)(3) certified, with a preference for programs demonstrating measurable outcomes. The funding period for local organizations extends from January to October 15th, while national organizations can apply in September.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on enhancing patient access to treatment in cardiovascular and metabolism areas. Nonprofit organizations classified as 501(c)(3) are eligible to apply for funding. The program emphasizes innovative initiatives that address healthcare disparities and improve patient outcomes through education, advocacy, and support services. Applications are evaluated based on design, capacity, and potential impact, with a preference for programs over event-based funding.

The Therapeutic Giving program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatment and advance health equity, particularly in immunology. Eligible nonprofit organizations can apply for support aimed at improving health outcomes through innovative programs. The initiative prioritizes measurable impacts over fundraising activities, emphasizing the importance of addressing healthcare disparities and promoting disease awareness efforts for diseases like rheumatoid arthritis and psoriasis.

The Therapeutic Giving: Oncology program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatments and services, promote health equity, and strengthen healthcare workforces. It supports programs that raise disease awareness, empower patients, and improve health systems with measurable outcomes. Eligible applicants include nonprofit organizations with 501(c)(3) status, emphasizing innovative programs addressing healthcare disparities and unmet needs.

The Therapeutic Giving program from Johnson & Johnson Innovative Medicine aims to support local and regional organizations focused on improving patient access to treatment and advancing health equity. Eligible applicants include 501(c)(3) nonprofit organizations, with funding preferences for programs that address significant healthcare disparities, mental health initiatives, and innovative solutions with measurable outcomes. The application period for local organizations runs from March 1 to May 31, while national organizations can apply in September.

The Therapeutic Giving initiative by Johnson & Johnson focuses on funding programs in neuroscience aimed at enhancing patient access to treatments and promoting health equity. Nonprofit organizations classified as 501(c)(3) can apply for support from March 1 to May 31. The initiative emphasizes innovative, measurable programs in areas like Alzheimer’s disease and mental health, prioritizing those that address healthcare disparities and improve quality of life for affected individuals.

The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports investigator-initiated clinical trials of natural products, including botanicals and dietary supplements. This funding opportunity aims to validate the pharmacokinetics and bioavailability of these products over three years in a phased approach. Successful trials will provide crucial data for further development and clinical application, emphasizing the importance of scientifically driven research in natural product efficacy.

The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) promotes innovative clinical trials on natural products, such as botanicals and dietary supplements. This funding opportunity supports studies that demonstrate significant scientific rationale and preliminary evidence for efficacy. Applications can explore various delivery methods and combinations with existing treatments to enhance outcomes. Funding is available for up to three years, aimed at bridging basic science discoveries into practical clinical applications.

The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) invites applications for mid-phase clinical trials involving natural products like botanicals and dietary supplements. The goal is to advance clinical testing through robust preliminary data, ensuring these products demonstrate measurable impacts on target engagement. Submission deadlines span from March 2024 to October 2026. Applications must focus on optimizing doses and identifying patient responders to inform future efficacy trials, aligning with NCCIH's research priorities.

The American Society for the Prevention of Cruelty to Animals (ASPCA) Open Access Publishing Fund Grant supports research that enhances animal welfare. This grant covers article processing fees for open access, peer-reviewed publications up to $5,000. Eligible applicants include U.S. citizens, residents, and researchers in animal welfare. The fund prioritizes submissions in areas such as cruelty prevention, animal sheltering, and veterinary care access, promoting impactful and innovative research.

The American Veterinary Medical Foundation (AVMF) Veterinary Pharmacology Fellowship Grant supports graduate students pursuing careers in veterinary pharmacology research. Funded in collaboration with the Veterinary Pharmacology Research Foundation, this grant offers up to $10,000 for a one-year fellowship. It covers expenses related to training, professional travel, stipends, and scholarly activities, aiming to enhance the number and quality of skilled researchers in the field.

The Edmond M. Dewan Young Scientist Scholarship for Atmospheric Sciences and Space Physics supports graduate students tackling challenges in atmospheric science and space physics. Funded by the Edmond M. Dewan Young Scientist Scholarship Fund, this scholarship encourages innovative research. Eligible applicants are active AGU student members pursuing graduate studies with a minimum GPA of 3.4. While scholarship recipients do not automatically receive travel grants for AGU’s Annual Meeting, they are encouraged to apply for them separately.

The ECosystem for Leading Innovation in Plasma Science and Engineering (ECLIPSE) program aims to advance plasma science research by addressing societal challenges through multidisciplinary collaboration. It encourages proposals that integrate fundamental scientific inquiries with technological applications, fostering innovation in areas such as environmental remediation, advanced manufacturing, and nanotechnology. Proposals should align with NSF priorities and promote diversity in STEM, enhancing workforce development and broadening participation from underrepresented groups.

The Bay Area Lyme Foundation's Emerging Leader Award supports innovative research in Lyme disease, offering two $150,000 grants to post-doctoral and early-career scientists. Applicants are encouraged to propose proof-of-concept projects that enhance diagnostics or therapeutics. The award seeks to attract talent and foster scientific leadership in biomedical sciences. Evaluation criteria include the potential for novel therapies, scientific rationale, and support from institutions. This opportunity is ideal for those new to tickborne disease research.

The Stanford Medicine Children’s Health Center for IBD and Celiac Disease offers funding for postdoctoral fellows and instructors to conduct innovative research focused on pediatric IBD and celiac disease. This initiative aims to nurture future researchers and prepare them for independent funding opportunities. Eligible research includes basic, clinical, epidemiological, and health policy studies related to maternal and child health. Funding supports substantial salary and benefits, ensuring commitment to impactful research in this critical area.

The NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) invites small businesses to submit applications for investigator-initiated clinical trials. This program particularly supports high-risk, hypothesis-driven studies that may involve non-routine interventions or unlicensed products. Letters of Intent are encouraged and due 30 days prior to the full proposal deadline. All applications must be submitted by 5:00 PM local time of the applicant organization.

The Stanford Children's Health Center for IBD and Celiac Disease offers Intramural Seed Grants to promote innovative research in pediatric diseases. This program supports high-risk, high-reward projects, encouraging multi-PI collaborations across disciplines. Awards of up to $100,000 per year for two years are available, aimed at generating preliminary data for future funding applications. Eligible applicants include Stanford faculty holding specific university positions. Proposals should focus on advancing understanding of pediatric IBD and celiac disease through various research approaches.

The Melanoma Research Resident and Fellowship Grant offers $10,000 to support early-career residents and fellows in conducting clinical or laboratory research focused on melanoma. This grant encourages innovative approaches to understanding prevention, detection, and treatment of melanoma, including special emphasis on ocular melanoma. Eligible candidates must have a qualified mentor and conduct research at a U.S. institution. This initiative aims to enhance the landscape of melanoma research and foster the next generation of researchers.

The Celiac Disease Foundation offers the Jocelyn Silvester Rising Villus Student Research Award to encourage medical students and residents to pursue celiac disease research. This prestigious award provides a $5,000 stipend for a 10-week mentored research experience across North America, honoring Dr. Jocelyn Silvester's contributions to the field. Recipients must secure a mentor and maintain good standing in their academic programs, ensuring a commitment to advancing celiac disease research.